Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience - Birtaş, Elif; Murat Özbalak; Ayşe Salihoğlu; Teoman Soysal; Ìhsan Karadoǧan; Semra Paydaş; Evren Özdemir; Birol Yıldız; Nuri Karadurmuş; Leylagül Kaynar; Münci Yağcı; Vildan Özkocaman; et al. (My University, 2019)
Keywords: Brentuximab vedotin; Internal medicine; Hodgkin lymphoma; Oncology; Medicine; Hematology; Lymphoma; Center (category theory); Refractory (planetary science); Biology; Chemistry